结合蛋白1 (SELENBP1) 在性结肠炎患者的保护作用
Gabriela Fonseca-Camarillo1,2, Janette Furuzawa-Carballeda3,4, Ángel A Priego-Ranero5
1Inflammatory Bowel Disease Clinic, Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición, Salvador Zubirán, Mexico City 14080, CP, Mexico.
Metabolites
|December 27, 2024
概括
结合蛋白1 (SELENBP1) 的表达在活跃的性结肠炎 (UC) 中较低. 在UC患者中,SELENBP1的升高与较轻的疾病过程相关.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 结合蛋白1 (SELENBP1) 在吸收中起作用,具有免疫调节作用.
- SELENBP1在性结肠炎 (UC) 病原和临床结果中的作用尚不清楚.
- 研究UC患者的SELENBP1表达对于了解其潜在影响至关重要.
研究的目的:
- 确定患有UC的患者结肠组织中SELENBP1表达的临床结果.
- 分析SELENBP1基因表达水平与UC临床活性之间的关联.
- 探索SELENBP1在UC患者的结肠组织中的局部化.
主要方法:
- 在34名UC患者和20名对照组中分析了SELENBP1的相对mRNA表达.
- 使用SPSS 19进行统计分析.
- 组织学评估和与SELENBP1表达水平的相关性.
主要成果:
- 与缓解和对照患者相比,在活跃的UC患者中,SELENBP1基因表达显着较低.
- 过度表达SELENBP1与更良性的临床过程有关,包括长期缓解和间歇性疾病模式.
- 主要在活性UC结肠组织的炎症透中发现了SELENBP1阳性细胞.
结论:
- SELENBP1的升高与性结肠炎的良性临床过程有关.
- 这项研究提供了SELENBP1在UC患者中具有免疫调节作用的第一个证据.
- 在UC中,SELENBP1可以作为疾病活动和预后的潜在生物标志物.
相关概念视频
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
310
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
310
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
305
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
305
Drugs for Treatment of Ulcerative Colitis in IBD
100
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
100
Inflammatory Bowel Disease I: Ulcerative Colitis
91
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
91
Peptic Ulcer Disease I: Introduction
81
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
81
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
474
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
474


